review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Ulf H Lerner | |
Pedro P C Souza | |||
P2860 | cites work | Bone Resorbing Activity in Supernatant Fluid from Cultured Human Peripheral Blood Leukocytes | Q70436209 |
Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages | Q73149209 | ||
Functional role of endogenous CD14 in lipopolysaccharide-stimulated bone resorption | Q73880868 | ||
Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption | Q79401044 | ||
Toll-like receptor 9 ligand blocks osteoclast differentiation through induction of phosphatase | Q80290283 | ||
Lack of Toll-like receptor 4 decreases lipopolysaccharide-induced bone resorption in C3H/HeJ mice in vivo | Q81055792 | ||
Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial | Q89174190 | ||
Haptoglobin Acts as a TLR4 Ligand to Suppress Osteoclastogenesis via the TLR4-IFN-β Axis | Q91930162 | ||
Toll-like receptor 7 regulates osteoclastogenesis in rheumatoid arthritis | Q92004915 | ||
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2 | Q22010443 | ||
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene | Q22299417 | ||
A Toll-like receptor recognizes bacterial DNA | Q24290668 | ||
Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved | Q24295020 | ||
Stimulation by toll-like receptors inhibits osteoclast differentiation | Q24301850 | ||
Toll-like receptor signalling | Q24570126 | ||
TLR signaling pathways | Q24570127 | ||
RANK is essential for osteoclast and lymph node development | Q24598872 | ||
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
The structural biology of Toll-like receptors | Q24619049 | ||
Human nutrition, the gut microbiome and the immune system | Q24620449 | ||
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer | Q24642646 | ||
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
Pathogen recognition and innate immunity | Q27861084 | ||
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity | Q28131769 | ||
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 | Q28185796 | ||
RANK-L and RANK: T cells, bone loss, and mammalian evolution | Q28203468 | ||
Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock | Q28244377 | ||
TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss | Q28265502 | ||
Is serum amyloid A an endogenous TLR4 agonist? | Q28267453 | ||
Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A | Q28284501 | ||
The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults | Q28289939 | ||
RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis | Q28293009 | ||
The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein | Q28307210 | ||
Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors | Q32024958 | ||
Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells | Q33803260 | ||
Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection | Q34007846 | ||
Porphyromonas gingivalis exacerbates ligature-induced, RANKL-dependent alveolar bone resorption via differential regulation of Toll-like receptor 2 (TLR2) and TLR4. | Q34298604 | ||
Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro | Q34459310 | ||
Direct Inhibition of Human RANK+ Osteoclast Precursors Identifies a Homeostatic Function of IL-1β | Q34467768 | ||
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans | Q34511374 | ||
Revised Estimates for the Number of Human and Bacteria Cells in the Body | Q34537872 | ||
TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB. | Q35085107 | ||
Effects of the gut microbiota on bone mass | Q35511709 | ||
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
Interferon-Gamma-Mediated Osteoimmunology | Q59356917 | ||
C5aR1 interacts with TLR2 in osteoblasts and stimulates the osteoclast-inducing chemokine CXCL10 | Q60628150 | ||
Addition of bisphosphonate to antibiotic and anti-inflammatory treatment reduces bone resorption in experimentalStaphylococcus aureus-induced arthritis | Q61480323 | ||
MyD88 and IL-1R signaling drive antibacterial immunity and osteoclast-driven bone loss during Staphylococcus aureus osteomyelitis | Q64052666 | ||
Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide | Q67901389 | ||
Endotoxin: Stimulation of Bone Resorption in Tissue Culture | Q69905970 | ||
Appearance of osteoclasts by injections of lipopolysaccharides in rat periodontal tissue | Q44976066 | ||
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus | Q45739890 | ||
Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. | Q46196784 | ||
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis | Q47761859 | ||
Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. | Q47944184 | ||
The bone-resorbing activities in tissue culture of lipopolysaccharides from the bacteria Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Capnocytophaga ochracea isolated from human mouths | Q50209836 | ||
Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis. | Q51383225 | ||
Local bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats. | Q51670417 | ||
Drosophila Toll and IL-1 receptor | Q52446674 | ||
Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through Toll-like receptor 2 with partial involvement of MyD88. | Q54732754 | ||
Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. | Q55033421 | ||
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β | Q57675150 | ||
c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 | ||
Dual Modulation of Osteoclast Differentiation by Lipopolysaccharide | Q58456589 | ||
CpG oligonucleotides: novel regulators of osteoclast differentiation | Q58456592 | ||
Leucine-rich repeats and pathogen recognition in Toll-like receptors. | Q35557275 | ||
Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-κB Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts | Q35953079 | ||
Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. | Q36054527 | ||
The gut microbiota regulates bone mass in mice | Q36153190 | ||
Serum amyloid A inhibits RANKL-induced osteoclast formation | Q36356941 | ||
MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha | Q36402446 | ||
IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1). | Q36444288 | ||
Recognition and signaling by toll-like receptors. | Q36527707 | ||
Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics | Q36951811 | ||
Signaling to NF-kappaB by Toll-like receptors | Q37009320 | ||
Taking a toll on the bones: regulation of bone metabolism by innate immune regulators | Q37118765 | ||
Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis | Q37169549 | ||
Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. | Q37372701 | ||
Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors | Q37438518 | ||
A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages | Q37581792 | ||
Interaction of staphylococci with bone. | Q37627430 | ||
Cytokine responses against periodontal infection: protective and destructive roles | Q37657662 | ||
Structural biology of the Toll-like receptor family | Q37872762 | ||
New insights into osteoclastogenic signaling mechanisms | Q38019255 | ||
Recognition of lipid A variants by the TLR4-MD-2 receptor complex | Q38081375 | ||
The role of cytokines in inflammatory bone loss | Q38134128 | ||
CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. | Q38357169 | ||
DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis | Q38709277 | ||
Links Between the Microbiome and Bone | Q38868831 | ||
Periodontitis prevalence in adults ≥ 65 years of age, in the USA. | Q38921846 | ||
Toll-Like Receptor Signaling and Its Inducible Proteins | Q39085329 | ||
RNA sensors of the innate immune system and their detection of pathogens. | Q39218571 | ||
Anti-tumor Activity of Toll-Like Receptor 7 Agonists | Q39377049 | ||
RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis | Q39780940 | ||
Bacterially induced bone destruction: mechanisms and misconceptions. | Q39825282 | ||
Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides | Q40332321 | ||
Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha | Q40618329 | ||
IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro | Q40814402 | ||
Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction | Q40962119 | ||
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. | Q41649459 | ||
Regulation of osteoclastogenesis by integrated signals from toll-like receptors | Q42202681 | ||
Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14. | Q42317462 | ||
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis | Q42972503 | ||
Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects | Q43833399 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | 1663 | |
P577 | publication date | 2019-07-17 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation | |
P478 | volume | 10 |
Q98465737 | Chronic Exposure of Gingival Fibroblasts to TLR2 or TLR4 Agonist Inhibits Osteoclastogenesis but Does Not Affect Osteogenesis |
Q104802177 | Gaucher disease: Basic and translational science needs for more complete therapy and management |
Q92650642 | The Challenge of Teaching Essential Immunology Laboratory Skills to Undergraduates in One Month-Experience of an Osteoimmunology Course on TLR Activation |